← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2010Last known activity
Sep 30, 2025
Timeline
1990s
- Jan 1, 1995
IrsiCaixa— Founded
Drugs by trial phase (28 distinct, 16 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (16)
- NCT07028385CollaboratorPhase 2Sep 30, 2025
- NCT06766825CollaboratorPhase 2Feb 7, 2025
- NCT06519357CollaboratorPhase 2Oct 28, 2024
- NCT05780073CollaboratorPhase 2Oct 16, 2023
- NCT05445674CollaboratorPhase 2Sep 22, 2022
- NCT05208125Lead sponsorPhase 1Mar 30, 2022
- NCT04720742Lead sponsorPhase 2Feb 28, 2021
- NCT04757818CollaboratorN/AFeb 17, 2021
- NCT04621123CollaboratorPhase 2Oct 30, 2020
- NCT02888756CollaboratorPhase 2Apr 4, 2017
- NCT02616874Lead sponsorPhase 1Feb 1, 2016
- NCT02513147CollaboratorPhase 4Jun 1, 2015
- NCT01712425Lead sponsorPhase 1Oct 1, 2012
- NCT01480713Lead sponsorPhase 3May 1, 2012
- NCT01346982CollaboratorPhase 4Mar 1, 2011
Details
- Founded
- Barcelona, ES Jan 1, 1995
- Last known activity
- Sep 30, 2025